Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria
NCT03469479
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
252
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
FOLFOX
PROCEDURE:
Hepatic resection
Sponsor
Sun Yat-sen University